Poster Sessions programme – RTI Forum 2026

Strolling Poster sessions will take place during the following slots:

Tuesday 3rd March 2026: 10:10–11:00 (session 1 to 3)
Wednesday 4th March 2026: 09:40–10:30 (session 4 to 6)

Posters will be displayed in the Poster Area, Atrium (Ground Floor).

Poster presenters are required to be present for the entire duration of their assigned session. Strict adherence to the schedule is mandatory.
Each presenter will have 3 minutes to introduce their scientific paper, followed by a brief discussion with the session chairs.
Posters are listed below by topic and alphabetically by presenting author. Each on-site panel will display the corresponding Poster #; please ensure your poster is hung according to the assigned number.

 
 

Poster Session 1 – Tuberculosis & NTM

Chairs: Charles Daley (United States), Michael Loebinger (United Kingdom)

×
Search :
#Presenter1st AuthorAbs codeTitle
1Rachel GallowayRachel Galloway1-1Hospitalisation and Survival Following Bacterial Respiratory Infections Vary by Pathogen and Underlying Disease
2Ranganath GangaRanganath Ganga1-2Diagnostic performance of CBNAAT in pleural biopsy samples obtained by thoracoscopy in patients with intermediate and lower likelihood of pleural tuberculosis: A prospective study from a high burden country.
3ANASTASIOS GKORTZOLIDISANASTASIOS GKORTZOLIDIS1-3Early-Onset Acute Liver Failure due to anti -TB treatment : A Life-Threatening Complication
4Fiona McDonaldFiona McDonald1-4What matters? Using patient experience to prioritise NTM Network Standards of Care
5Divya Obla Amar BapuDivya Obla Amar Bapu1-5Omadacycline as an alternative to macrolides within maintenance regime in treating Mycobacterium abscessus pulmonary disease in children with Cystic Fibrosis: a case series
6Kate TamayoKate Tamayo1-6A Clinical Audit of Post-TB Management and Follow-Up at Liverpool University Hospital Trust

 
 

Poster Session 2 – Bronchiectasis

Chairs: Stefano Aliberti (Italy)

Search :

#Presenter1st AuthorAbs codeTitle
1Rachel AndersonRachel Anderson2-1Evaluation of Immunological Testing for Allergic Bronchopulmonary Aspergillosis: A Ten-Year, Two-Cohort Comparison from a UK Tertiary Centre
2Hannah DicksonHannah Dickson2-2Characterisation of airway high-mobility group box 1 in bronchiectasis, using bronchoalveolar lavage proteomics
3Ashleigh FoubisterAshleigh Foubister2-3Impaired B-cell Responses to P. aeruginosa and their Impact on Antibody Production in Bronchiectasis
4Rebecca HaresRebecca Hares2-4A breath of fresh nitrogen – Lung Clearance Index as a diagnostic and monitoring marker of lung health in children with bronchiectasis unrelated to CF
5Röhmel JobstRöhmel Jobst2-5Eradication of a macrolide-resistant Mycobacterium abscessus in a patient with Primary Ciliary Dyskinesia caused by biallelic mutations in DNAH1 gene with a multi-drug regime including inhalative liposomal amikacin
6Jie Ying LeeJie Ying Lee2-6Investigating Disulfiram as a Dual-Action Therapy for Pseudomonas aeruginosa Infection and Bronchiectasis
7Holly LindHolly Lind2-7Performance characteristics of the bronchiectasis health questionnaire: Data from the EMBARC-BRIDGE study
8Jaa Ming (Ben) NewJaa Ming (Ben) New2-8Carotid-femoral Pulse Wave Velocity in Bronchiectasis: A case-control study
9Duncan SandersonDuncan Sanderson2-9The Importance of Autoantibodies in Infective Bronchopulmonary Exacerbations in Bronchiectasis Patients

 
 

Poster Session 3 – Clinical Cases

Chairs: Anthony De Soyza (United Kingdom), Lucy Morgan (Australia)

Search :

#Presenter1st AuthorAbs codeTitle
1Jessica Cemlyn-JonesEduarda Paiva3-1From Cats to Lungs: Pasteurella multocida as a Respiratory Pathogen in Chronic Pulmonary Disease
2Jessica Cemlyn-JonesEduarda Paiva3-2The Microbiological Conundrum in a patient with Bronchiectasis: Challenges and Future Directions
3Ana CorreiaAna Correia3-3Not Just Another Pneumonia: Infliximab and the Risk of Legionella Infection
4Fernanda GamboaFátima Barbosa3-4Phage Therapy for Difficult-to-Treat Airway Pathogens: Clinical Response in Three Treated Patients
5Ayooluwa OmoloyeAyooluwa Omoloye3-5Effect of CFTR modulators commenced in patients over the age of 50 years
6Dilbag SinghDilbag Singh3-6Case Series on Spontaneous Bronchial Cartilage Fractures: A Rare Airway disorder  in Elderly Patients.
7Dilbag SinghDilbag Singh3-7Ultra-Rare Pulmonary Disorders: Four Clinical Unique Cases Redefining Diagnostic Boundaries
8Tina TsiskarauliTina Tsiskarauli3-8Beyond the Lung Fields: Unveiling the True Cause of Recurrent Pneumonia in Pediatrics
9Emily WardEmily Ward3-9Plugged out

 
 

Poster Session 4 – Viral Respiratory Infections, COVID-19 & Vaccines

Chairs: Debby Bogaert (United Kingdom), Merete Long (United Kingdom)

Search :

#Presenter1st AuthorAbs codeTitle
1Harrison BottHarrison Bott4-1Bacterial co-infection in hospital-attended patients with laboratory-confirmed influenza infection: a systematic review and meta-analysis
2Aishana JoshiAishana Joshi4-2Pulmonary rehabilitation in post-COVID recovery in rural Nepal: A collaborative model from resource-limited primary hospital in low- and middle-income country
3Aishana JoshiAishana Joshi4-3Climate change and emergence of COVID-19- Dengue co-infection in temperate region of Nepal: Insights from a tertiary hospital of a low and middle-income country
4Hazique Parvaiz KoulHazique Parvaiz Koul4-4Influenza Vaccination Practices following the COVID 19 pandemic among Hospital Physicians and Physician Trainees in North India
5Sangeetha Sarthi HaleshappaSangeetha Sarthi Haleshappa4-5Assessment of Prescribing Practices of Oral Antiviral Drugs for In-Patients with Influenza according to NICE guidelines
6Yangqing ZhanYangqing Zhan4-6Efficacy and Safety of Single-dose Pixavir Marboxil for Acute Uncomplicated Influenza: A Phase III, Randomised, Double-blind, Placebo-controlled Trial

 
 

Poster Session 5 – Antibiotic Resistance, Optimising Treatment & Diagnostics

Chairs: Andrea Collins (United Kingdom)

Search :

#Presenter1st AuthorAbs codeTitle
1Sean Campbell CampbellSean Campbell Campbell5-1When controls speak louder than samples: Contamination, Low Biomass and the Lung Microbiome
2Viktorija LodeikinaViktorija Lodeikina5-2Tracking the Rise: Mycoplasma Pneumoniae Infections and Macrolide Resistance in Latvia 2023-2024.
3Seegobin NidhiJagannath Vinita5-3A SECONDARY ANALYSIS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY OF V116, A PNEUMOCOCCAL CONJUGATE VACCINE, IN CHILDREN AND ADOLESCENTS WITH INCREASED RISK OF PNEUMOCOCCAL DISEASE (STRIDE-013)
4Hollian RichardsonHollian Richardson5-4The sputum microbiota and long-term clinical outcomes in patients with chronic obstructive pulmonary disease
5Hannah WrightHannah Wright5-5A review of UK data generated during the first year of a national maternal RSV immunisation programme
6Amelia YoungAmelia Young5-6The role of environmental factors in predicting the risks of winter respiratory diseases

 
 

Poster Session 6 – Fungal & Complex Airway Infections

Chairs: Stefano Aliberti (Italy)

Search :

#Presenter1st AuthorAbs codeTitle
1Jessica Cemlyn JonesSofia Botelho Teixeira6-1Scedosporium apiospermum in bronchiectasis - colonisation versus infection: a case report
2Louise JacksonLouise Jackson6-2Multiplex molecular detection of pathogens and clinical instability in longitudinal sputum sampling: a post-hoc analysis of the POSTED study
3Fiona McDonaldFiona McDonald6-3A Systematic Review of Aspergillus-Related Disease in Bronchiectasis
4Antonella MulèAntonella Mulè6-4When Sweet’s Syndrome Reveals Paucibacillary Pulmonary Tuberculosis: A Diagnostic and Therapeutic Pitfall
5Ahmad SanaAkhil Sawant6-5ATYPICAL PRESENTATION OF MYCOBACTERIUM AFRICANUM INFECTION MIMICKING SARCOMA: A DIAGNOSTIC CHALLENGE IN A NON-ENDEMIC SETTING
6Dilbag SinghDilbag Singh6-6Hydropneumothorax with Bronchopleural Fistula as an Unusual Complication of Allergic Bronchopulmonary Aspergillosis: A Rare and only Case Series in the world .
7Tina VrenkoTina Vrenko6-7Chronic pulmonary aspergillosis: real-life clinical practice in a tertiary centre